FDANonrulemakingFDA-2023-D-5016
Who commented on this docket
Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices; Draft Guidance for Industry; Availability
2 organizations filed 2 public comments on Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 515d ago.
Organizations
2
Comments
2
RIN
—
Comment window
closed 515d ago
Abstract
OPEN
Commenters (2)
- Advanced Medical Technology Associationtrade assoc.1 filing · confidence 97%
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.